Mariana Langiewicza 50 Lódzkie Konstantynow 95-050 Poland Activity: Design & Manufacture of Color, Additive Concentrate & Specialty Compounds Activity: Design and Manufacture of Colour and Additive Concentrates, Thermoplastic Resins and Specialty Compounds Facility: Avient Pakistan (Private) Limited 1-A/1, Sector-20 Korangi Industrial Area Korangi, Sindh 74900 Pakistan Facility: Avient Corporation - Lahnstein, Germany Hohenrhein 1 56112 Lahnstein, Rheinland-Pfalz Germany Activity: Design and Manufacture of Colour and Additive Concentrates, Thermoplastic Resins and Specialty Compounds Activity: Design and Manufacture of colour and additive concentrates, thermoplastic resins and specialty compounds Facility: Avient Corporation - Esenyurt, Turkey Orhan Gazi Mahallesi 1683 Sokak No:6 34538 Esenyurt Istanbul Turkey Facility: Avient Corporation - Jurong, Singapore No. 8 Third Chin Bee Road Jurong Industrial Estate Jurong 618684 Singapore Activity: Design and Manufacture of Specialty Engineered Thermoplastics Activity: Design and Manufacture of Colorants and Additives for Plastics Page 5 of 10 ABS Quality Evaluations Avient Corporation ISO 14001:2015 Certificate Of Conformance ANNEX At Below Facilities: Validity of this certificate may be confirmed at www.abs-qe.com/cert_validation. Activity: Design and Manufacture of Colorants and Additives for Plastics Page 6 of 10 ABS Quality Evaluations Avient Corporation ISO 14001:2015 Certificate Of Conformance ANNEX At Below Facilities: Validity of this certificate may be confirmed at www.abs-qe.com/cert_validation.

EXTRUDER Screw 1" to 6" deep flighted metering screw 3:1 compression ratio Tooling Tubing type – zero land (for smaller sizes) Pressure type – for 1" size or larger Die Tubing type – low DDR Pressure type – short land L/D 24:1 or higher Screen Pack 20/40/20 Mesh Cooling Trough 120–150 °F (50–65 °C) recommended Dryer Hot air or desiccant type, 4 hours at 175–185 °F PROCESSING Temperature Wire Preheat None Feed Zones 290–300 °F Transition 320–340 °F Metering 340–350 °F Head/Die 350–365 °F Target Melt 350–365 °F Maximum Melt 390 °F Purge Compound HDPE www.avient.com Copyright © 2020, Avient Corporation.

EXTRUSOR Tornillo Tornillo de regulación de rosca profunda de 1" a 6" Relación de compresión 3:1 Cabezal De tubo: sin hilera (para tamaños pequeños) De presión: para tamaños de 1" o superiores Dado De tubo: bajo coeficiente de estirado De presión: hilera corta L/D 24:1 o superior Paquete de mallas Malla de 20/40/20 Canal de enfriamiento 50–65°C recomendado Secador Aire caliente o desecante, 4 horas a 79–85°C PROCESAMIENTO Temperatura Precalentamiento del alambre Ninguno Zonas de alimentación 143–149°C Transición 160–171°C Dosificación 171–176°C Cabezal/dado 176–185°C Material fundido 176–185°C Fusión máxima 199°C Compuesto de purga HDPE www.avient.com Copyright © 2020, Avient Corporation.

VersaflexTM PF Versaflex PF VOC Versaflex PF VERSAFLEX PF VOC 39 LDPE / 13 Versaflex PF VERSAFLEX PF 39 LDPE / 13 Versaflex PF N / 2 5 m m N / 2 5 m m F = 25 ° C 7 I = 25 ° C 20 MD6741 / MD6700 VERSAFLEX PF TM +86 021 60284888 www.avient.com VERSAFLEX™ PF 1 CF6751 PP 2 2420K LDPE Versaflex™ PF MD6727 Versaflex™ PF MD6741 Versaflex™ CF 6751 Versaflex™ PF MD6649 Versaflex™ PF 9512 Versaflex™ CF 8888N-A Versaflex™ PF MD6666 Versaflex™ PF MD6748 Versaflex™ PF MD6700 Versaflex™ CF 9000 PP PVC Tg (°C) -26 -43 -30 -26 -5 1 -6 0 5 / (Shore A) 50 49 35 37 38 35 37 31 30 19 MFI (190°C, 2.16kg) (g/10min) / / / 15 5 15 20 3 5 27 MFI (230°C, 2.16kg) 8 20 8 / / / / / / / 1 LDPE 2420k2/LDPE 2420k/Versaflex™ =4.5/4.5/1 ; =50um (N/25mm) 25°C 20 1.3 1.8 7.9 2.5 2.2 2.7 3.3 3.0 3.7 4.3 75°C 7 5.7 2.9 7.2 3.1 4.0 4.3 4.3 5.5 5.6 / PMMA (N/25mm) 25°C 20 1.8 2.0 7.2 2.6 2.8 3.0 3.6 3.3 3.9 4.9 75°C 7 5.5 4.7 7.1 3.5 / 4.7 6.5 5.8 6.9 /

% Solids Color Index pH Typical Weight Lbs/Gal WHITE 10WDN03 Titanium Dioxide, Rutile 60 73 PW-6 9 16.7 YELLOW 12WDN01 Diarylide AAOT GS 35 43 PY-14 8.8 9.4 12WDN02 Diarylide HR RS 37 44 PY-83 8.8 9.6 12WDN03 Arylide GY RS 38 45 PY-74 8.8 9.2 81WDN01 Iron Oxide 55 63 PY-42 8.8 14.5 ORANGE 15WDN01 Pryazolone YS 40 45 PO-13 8.8 9.2 15WDN03 Dianisidine RS 35 37 PO-16 8.8 9.2 15WDN06 DNA Orange RS 31 43 PO-5 8.8 9.7 RED 22WDN01 Lithol Rubine BS 33 40 PR-57 8.8 9.8 21WDN01 Naphthol BS 35 43 N/A 8.8 9.5 25WDN01 Red 2B, Ca BS 34 41 PR-48:2 8.8 9.6 28WDN01 Red 2B, Ba YS 36 44 PR-48:1 8.8 9.5 82WDN02 Iron Oxide 57 66 PR-101 8.8 16 BLUE 40WDN01 Phthalocyanine RS 35 46 PB-15 8.8 9.7 40WDN03 Phthalocyanine GS 38 43 PB-15:3 8.8 9.8 GREEN WDN-27822 Phthalocyanine BS 42 53 PG-7 8.8 10.5 VIOLET/MAGENTA 24WDN02 Carbazole 35 48 PV-23 8.8 9.6 24WDN03 Quinacridone 31 39 PV-19 8.8 9.6 24WDN05 Quinacridone 30 41 PR-122 8.8 10 BLACK 90WDN01 Carbon Black 45 49 PB-7 8.8 9.3 WDN RS = Red Shade YS = Yellow Shade BS = Blue Shade GS = Green Shade HR = Heat-Resistant www.avient.com Copyright © 2020, Avient Corporation.

KEY CHARACTERISTICS • Manufactured at four ISO 13485 certified manufacturing sites, providing global consistency and increased security of supply • Documented change control beyond CAS number, reducing risk of change • Non-phthalate and formulated without animal- derived substances • Standard concentrates in a PE carrier and on request in PP • Pre-colored formulations can be supplied in specific resins selected for the application REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 and USP biological evaluation - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities • Registered Drug Master File (Type III) • Food contact established with FDA/EU* APPLICATION BULLETIN DRUG TYPE COLOR DESCRIPTION PANTONE REFERENCE AVIENT PRODUCT CODE PE BASED Adrenergic agonist combinations Light Green 373 C PE6M176349 Adrenergic agonists Purple 2583 C PE4M176057 Anti-infectives Tan 467 C PE8M176130 Anti-inflammatory, nonsteroidal Grey Cool Grey 4 C PE7M176184 Anti-inflammatory, steroids Pink 197 C PE3M176237 Anti-inflammatory, immunomodulators Olive Green 5763 C On request Beta-blockers Yellow Yellow C PE1M176160 Beta-blocker combinations Dark Blue 281 C PE5M176272 Carbonic anhydrase inhibitors Orange 1585 C PE2M176089 Cytotoxic Black 6 C PL9M176008 Miotics Dark Green 348 C PE6M176267 Mydriatics and cycloplegics Red 1797 C PE3M176236 Prostaglandin analogues Turquoise 326 C PE5M176273 Healthcare use limitations apply—see below.

6 Are you able to provide geolocation data for your facilities? For example, the Edgetek PKE series consists of specialty engineered polyketone (PK) 59 thermoplastics designed to offer manufacturers a high-performing, cost-competitive, and eco-conscious alternative to traditional nylons (PA66 and PA6). This serves as a formal way for stockholders to influence the company’s strategy. 6.

تاريخ التحديث: فبراير 2021 سياسة Avient العاملية بشأن مكافحة االحتكار املحتويات 1 دليل االمتثال 1 نظرة عامة عىل السياسة 2 نظرة عامة عىل قوانني مكافحة االحتكار األمريكية 3 انتهاكات قانون مكافحة االحتكار 3 الجوانب املثرية للمخاوف املحتملة فيام يتعلق مبكافحة االحتكار 5 الخالصة 6 اإلبالغ عن االنتهاكات املحتملة 6 Avient الخط الساخن لألخالقيات يف 7 القامئة املرجعية ملكافحة االحتكار 9 املرجع الرسيع: األوامر والنواهي فيام يتعلق مبكافحة االحتكار دليل االمتثال تلتزم Avient بتعزيز املنافسة العادلة واقتصاد السوق الحرة. الخط الساخن لألخالقيات يف https://www.Avient.com/company/policies-and- governance/ethics-hotline فتاه 1-877-228-5410 6 المحتويات سياسة مكافحة االحتكار المنقحة لعام 2021 mailto:ethics.officer%40avient.com? ال تحرض أي اجتامعات مع املنافسني )مبا يف ذلك تجمعات االتحادات . 6 التجارية( حيث تتم مناقشة األسعار أو أي من املوضوعات املشار إليها أعاله.

$14M+ For United Way Since 2007 1.8 1.4 1 .6 .2 2007 2010 2013 2016 2019 $ M IL L IO N S U .S . For Unit 1.8 1.4 1 .6 .2 2007 2010 2013 20 $ M IL L IO N S U .S . D O L L A R S *Pro Forma for sale of DSS 2009 2010 2011 2012 2013 2014 2015 2016* 2017* 2018 2018 2019 $2.21 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $2.43 $2.06 $1.96 Pro Forma for sale of PP&S $1.69 $1.51 12 31 2018 3 31 2019 6 30 2019 9 30 2019 12 31 2019 +32% 2019 POL Stock Price Performance $ U .S .

AVNT-2024.03.31-News Release 1 NEWS RELEASE FOR IMMEDIATE RELEASE Avient Announces First Quarter 2024 Results • First quarter GAAP EPS from continuing operations of $0.54 compared to $0.23 in the prior year quarter • First quarter adjusted EPS of $0.76 exceeded guidance of $0.68 primarily as a result of better-than-expected customer demand from defense applications and lower raw material costs • First quarter adjusted EPS increased 21% over the prior year driven by improved margins from lower raw material costs and favorable mix, and lower net interest expense • Revised 2024 full-year adjusted EPS guidance range to $2.50 to $2.65, from prior guidance of $2.40 to $2.65 given strong first quarter results; Revised full-year guidance range reflects 6% to 12% growth in adjusted EPS over the prior year CLEVELAND – May 7, 2024 – Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable materials solutions, today announced its first quarter results for 2024. Rose Vice President, Marketing and Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com 6 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended March 31, 2024 2023 Sales $ 829.0 $ 845.7 Operating income 94.0 57.1 Net income from continuing operations attributable to Avient shareholders 49.4 20.8 Diluted earnings per share from continuing operations attributable to Avient shareholders $ 0.54 $ 0.23 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. 2) Tax adjustments include the net tax impact from non-recurring income tax items, adjustments to uncertain tax position reserves and the establishment, reversal or changes to valuation allowances. 9 Attachment 4 Avient Corporation Condensed Consolidated Balance Sheets (In millions) (Unaudited) March 31, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 444.3 $ 545.8 Accounts receivable, net 475.3 399.9 Inventories, net 354.0 347.0 Other current assets 117.1 114.9 Total current assets 1,390.7 1,407.6 Property, net 1,021.7 1,028.9 Goodwill 1,700.1 1,719.3 Intangible assets, net 1,546.5 1,590.8 Other non-current assets 217.1 221.9 Total assets $ 5,876.1 $ 5,968.5 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Short-term and current portion of long-term debt $ 9.6 $ 9.5 Accounts payable 428.3 432.3 Accrued expenses and other current liabilities 294.2 331.8 Total current liabilities 732.1 773.6 Non-current liabilities: Long-term debt 2,069.4 2,070.5 Pension and other post-retirement benefits 66.3 67.2 Deferred income taxes 280.0 281.6 Other non-current liabilities 390.5 437.6 Total non-current liabilities 2,806.2 2,856.9 SHAREHOLDERS' EQUITY Avient shareholders’ equity 2,321.3 2,319.2 Noncontrolling interest 16.5 18.8 Total equity 2,337.8 2,338.0 Total liabilities and equity $ 5,876.1 $ 5,968.5 10 Attachment 5 Avient Corporation Condensed Consolidated Statements of Cash Flows (Unaudited) (In millions) Three Months Ended March 31, 2024 2023 Operating activities Net income $ 49.7 $ 20.4 Adjustments to reconcile net income to net cash used by operating activities: Depreciation and amortization 43.8 48.7 Accelerated depreciation 0.5 1.8 Share-based compensation expense 3.3 3.2 Changes in assets and liabilities: Increase in accounts receivable (81.9) (40.2) (Increase) decrease in inventories (12.3) 3.8 Increase (decrease) in accounts payable 1.7 (9.9) Accrued expenses and other assets and liabilities, net (47.6) (50.0) Net cash used by operating activities (42.8) (22.2) Investing activities Capital expenditures (24.4) (20.3) Net proceeds from divestiture — 7.3 Proceeds from plant closures 2.0 — Other investing activities (2.1) — Net cash used by investing activities (24.5) (13.0) Financing activities Cash dividends paid (23.5) (22.5) Repayment of long-term debt (2.7) (0.8) Other financing activities (1.9) (2.3) Net cash used by financing activities (28.1) (25.6) Effect of exchange rate changes on cash (6.1) 2.4 Decrease in cash and cash equivalents (101.5) (58.4) Cash and cash equivalents at beginning of year 545.8 641.1 Cash and cash equivalents at end of period $ 444.3 $ 582.7 11 Attachment 6 Avient Corporation Business Segment Operations (Unaudited) (In millions) Operating income and earnings before interest, taxes, depreciation and amortization (EBITDA) at the segment level does not include: special items as defined in Attachment 3; corporate general and administration costs that are not allocated to segments; intersegment sales and profit eliminations; share-based compensation costs; and certain other items that are not included in the measure of segment profit and loss that is reported to and reviewed by the chief operating decision maker.